About Us
Heranova is a global Women’s Health company dedicated to addressing unmet medical needs in women. The current state of women’s healthcare is far from acceptable, with many health needs largely ignored.
We are committed to addressing these unmet healthcare needs throughout a woman’s life, including reproductive health, pregnancy, and menopause.
Our Story
Women play a critical role in modern societies and economies. However, there is a huge gap in knowledge about Women’s Health, leading to a large number of unmet medical needs. Even till 2020, only ~1% of healthcare research and innovation investment was made in female-specific conditions beyond oncology.
At Heranova, providing innovative solutions to address these key unmet needs is our first priority. To thoroughly bridge each care gap, we take on a “Women Centric” and “Solution Driven” approach which aims to complete the care journey from diagnosis to treatment for every woman.
Women Centric
Integrated Solution
Our Approach
Breakthrough diagnostic tests for accessible, accurate, and earlier identification of debilitating diseases (e.g., endometriosis) and treatment guidance (e.g., IVF).
Our Team Members
Scientific Advisors
Dr. Hugh Taylor Chief of OB/GYN, Yale-New Haven Hospital
- Anita O'Keeffe Young Prof of OB/GYN, and Reproductive Sciences and Prof of Molecular, Cellular, and Developmental Biology
- Recipient of ten National Institutes of Health research grants and directs The Yale Center for Reproductive Biology
- President of the Society for Reproductive Investigation and president of the American Society for Reproductive Medicine
- Member of the National Academy of Medicine
Dr. Will DereInternal Medicine, University of Utah
- Anita O'Keeffe Young Prof of OB/GYN, and Reproductive Sciences and Prof of Molecular, Cellular, and Developmental Biology
- Board members at Radius, BioMarin, Mersana and Seres Therapeutics
- International Chief Medical Officer at Amgen
- VP of Endocrine, Bone and General Medicine at Eli Lilly
Dr. Guo Sun-Wei Professor, Fudan University OB/GYN Hospital
- Founder, former President of Asia Endometriosis and Adenomyosis Association
- Board Member, trustee of World Endometriosis Society
- Scientific Advisor of Endometriosis Foundation of America
- Adjunct professor at the Department of OB/GYN and Reproductive Sciences of Michigan State University
Dr. Carlos SimónFounder, Igenomix Foundation
- Professor of OB/GYN at the University of Valencia; Adjunct Clinical Professor of Baylor College of Medicine
- >25 years’ reproductive health experience, received Prize Jaime I, the KY Cha Award, the American Society for Reproductive Medicine’s Award
- Co-founder and CSO at Igenomix (acquired by Vitrolife)
Dr. Denny Sakkas Scientific Director, Boston IVF
- Internationally recognized embryologist; Editorial Board of 5 leading journals in reproductive medicine
- CSO at Molecular Biometrics
- President of the Society for Reproductive Investigation and president of the American Society for Reproductive Medicine
- Associate Professor, Department of OB/GYN & Reproductive Sciences, Yale University
Global Footprint
In the US
- Diagnostic and therapeutic R&D capability specialized in Women’s Health
- Global BD and partnership
- Global medical strategy
In Asia-Pacific
- Operating diagnostic lab (China clinical lab certification, CAP/CLIA certification)
- Established sales team and channels
- Extensive local commercialization expertise
